CEO: | Adrian Kinkaid |
Chairman: | Simon Gordon Douglas |
Chief Scientific Officer: | Richard John Buick |
Non-Executive Dir: | Colin Walsh, Matthew Baker |
Address: | Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom, BT17 0QL |
Website: | https://www.fusionantibodies.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BDQZGK16 |
Currency | UK Pounds |
Share Price | 16.60p |
Change Today | 0.35p |
% Change | 2.15 % |
52 Week High | 17.50p |
52 Week Low | 3.25p |
Volume | 318,687 |
Shares Issued | 113.66m |
Market Cap | £18.87m |
RiskGrade | 464 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
11:59 | 3,000 @ 17.00p |
11:34 | 3 @ 16.95p |
11:03 | 10,011 @ 16.94p |
10:39 | 256 @ 16.23p |
10:32 | 3 @ 16.95p |
Chair | Simon Gordon Douglas |
CEO | Adrian Kinkaid |
You are here: research